Donald Notman

Donald Notman is a declared insider of Ocular Therapeutix, Inc (finance chief), with filings sourced from SEC (Form 4). Over a trading history stretching from 7 December 2017 to 12 February 2026, the count stands at 18 filings.

On the open market, the record shows 3 purchases worth €95k and 9 sales worth €399k. The net balance comes to €303k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 6 share grants. 2026 to date brings no purchases and 3 sales.

In size, the median ticket on the buying side is €16k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 17 February 2026, the filings show an open-market sale worth €87k in Ocular Therapeutix, Inc. The last purchase on record was published on 17 June 2019, which is 2,702 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.